Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02159222 · ClinicalTrials.gov registry record · NA

Sepsis Trial of Early Physical Therapy Outside the ICU

A NA study, sponsored by University of Michigan.

Terminated
Registry status
NA
Development phase
16
Enrollment target

NCT02159222: Clinical Trial NA study, sponsored by University of Michigan.

NCT02159222 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02159222, a NA study, was terminated before completion, sponsored by University of Michigan.

TERMINATED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether an additional physical therapy program can improve the mobility and functional outcomes of patients diagnosed with severe sepsis (an illness in which the body has a severe response to bacteria or other germs and develops worsened function of a major organ such as the kidneys, heart, or lungs).

Primary Outcome

Participants will be followed for the duration of their hospitalization, a predicted average length of stay of 5 days. This outcome will be assessed at baseline and at each study protocol physical therapy session during the index hospitalization.

Interventions

  • PROCEDURE Additional physical therapy

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-04
Est. Completion 2019-09
Phase NA
University of Michigan

1,327 total trials

Why NCT02159222 stopped before completion

NCT02159222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Additional physical therapy is the first listed.

NCT02159222 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02159222 about?

NCT02159222 is a clinical study titled "Sepsis Trial of Early Physical Therapy Outside the ICU". The purpose of this study is to determine whether an additional physical therapy program can improve the mobility and functional outcomes of patients diagnosed with severe sepsis (an illness in which the body has a severe response to bacteria or other germs and develops worsened function of a major ...

What is the current status of trial NCT02159222?

This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2014-04. Estimated completion is 2019-09.

What interventions are being tested in trial NCT02159222?

The interventions under investigation include: Additional physical therapy (PROCEDURE).

Who is sponsoring clinical trial NCT02159222?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02159222's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02159222, the US trial registry maintained by the National Library of Medicine. NCT02159222 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.